Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-02-12

Clinical Trial Update: A Randomised Trial Comparing the Ovarian Response of a Starting Dose of Either 10 μg or 15 μg Follitropin Delta (FE 999049) to a Starting Dose of Either 150 IU or 225 IU Follitropin Alfa (GONAL-F) in Conventional Regimens in China [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial in China compared starting doses of Follitropin delta versus Follitropin alfa for ovarian stimulation in women with infertility; the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Follitropin Delta (follicle-stimulating hormone delta)
  • Follitropin alfa (folitropin alfa)

Snippet

Sponsor: Ferring Pharmaceuticals | Conditions: Infertility, Female | Phase 3 | Status: COMPLETED | Results posted: 2026-02-12